Medac Gesellschaft für klinische Spezialpräparate m.b.H.
Medac Gesellschaft für klinische Spezialpräparate m.b.H. is a Private limited company (Ltd.) registered in Germany under HRB 12042 PI Pinneberg, and its current status with Handelsregister (Commercial Register) is active. The company was incorporated on 29 October 1971 and lists its registered address as Wedel, Germany. 5 shareholders are on record for Medac Gesellschaft für klinische Spezialpräparate m.b.H., including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 5 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Medac Gesellschaft für klinische Spezialpräparate m.b.H., held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG.
The largest of these is Wilfried Mohr, holding 43.1% — the largest recorded stake — followed by John Welding at 21.6%; the remaining 3 shareholders shown hold smaller stakes.
Every shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Wilfried Mohr | 43.1% | Handelsregister (Commercial Register) | |
| John Welding | 21.6% | Handelsregister (Commercial Register) | |
| Claus-Olaf Welding | 21.6% | Handelsregister (Commercial Register) | |
| Peter Voß | 7.8% | Handelsregister (Commercial Register) | |
| MATEX Verwaltungsgesellschaft mbH | 5.9% | Handelsregister (Commercial Register) |
Officers
5
Four of the 5 officer records shown for Medac Gesellschaft für klinische Spezialpräparate m.b.H. are current appointments, filed with Handelsregister (Commercial Register). Frank Lucaßen (appointed 2022-11-01) serves as Geschäftsführer (managing director); Sigrid Tuschen (appointed 2018-04-04), Florian Ende (appointed 2019-04-17) and Ingo Guhde (appointed 2021-09-30) all serve as Officer. The remaining 1 record shown (Uwe Pichlmeier-Fritz) is a former appointment that has since been resigned.
The register reports 34 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Medac Gesellschaft für klinische Spezialpräparate m.b.H. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Medac Gesellschaft für klinische Spezialpräparate m.b.H. has no recorded parent company — it sits at the top of its own group structure, with 15 subsidiaries recorded beneath it across 10 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 15 subsidiaries span Germany, Norway, Czechia, Finland, Italy, Denmark, and 4 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 15 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Medac Gesellschaft für klinische Spezialpräparate m.b.H.
Germany
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Medac Gesellschaft für klinische Spezialpräparate m.b.H.?
Five shareholders are currently on record for Medac Gesellschaft für klinische Spezialpräparate m.b.H., held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG. The largest of these is Wilfried Mohr, holding 43.1% — the largest recorded stake — followed by John Welding at 21.6%; the remaining 3 shareholders shown hold smaller stakes. Every shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.
Who is Medac Gesellschaft für klinische Spezialpräparate m.b.H.'s UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for Medac Gesellschaft für klinische Spezialpräparate m.b.H. is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does Medac Gesellschaft für klinische Spezialpräparate m.b.H. have on record?
5 shareholders are shown on record for Medac Gesellschaft für klinische Spezialpräparate m.b.H..
What is Medac Gesellschaft für klinische Spezialpräparate m.b.H.'s company registration number?
Medac Gesellschaft für klinische Spezialpräparate m.b.H.'s registration number is HRB 12042 PI Pinneberg, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is Medac Gesellschaft für klinische Spezialpräparate m.b.H. still an active company?
Medac Gesellschaft für klinische Spezialpräparate m.b.H.'s status on Handelsregister (Commercial Register) is listed as active.
When was Medac Gesellschaft für klinische Spezialpräparate m.b.H. incorporated?
Medac Gesellschaft für klinische Spezialpräparate m.b.H. was incorporated on 29 October 1971, according to Handelsregister (Commercial Register).
What is Medac Gesellschaft für klinische Spezialpräparate m.b.H.'s registered address?
The registered address on file for Medac Gesellschaft für klinische Spezialpräparate m.b.H. is Wedel, Germany.
What legal structure is Medac Gesellschaft für klinische Spezialpräparate m.b.H. registered as?
Medac Gesellschaft für klinische Spezialpräparate m.b.H. is registered as a Private limited company (Ltd.) in Germany.
Who are the officers/directors of Medac Gesellschaft für klinische Spezialpräparate m.b.H.?
Four of the 5 officer records shown for Medac Gesellschaft für klinische Spezialpräparate m.b.H. are current appointments, filed with Handelsregister (Commercial Register). Frank Lucaßen (appointed 2022-11-01) serves as Geschäftsführer (managing director); Sigrid Tuschen (appointed 2018-04-04), Florian Ende (appointed 2019-04-17) and Ingo Guhde (appointed 2021-09-30) all serve as Officer. The remaining 1 record shown (Uwe Pichlmeier-Fritz) is a former appointment that has since been resigned. Management authority at Medac Gesellschaft für klinische Spezialpräparate m.b.H. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Medac Gesellschaft für klinische Spezialpräparate m.b.H. have a parent company or subsidiaries?
Medac Gesellschaft für klinische Spezialpräparate m.b.H. has no recorded parent company — it sits at the top of its own group structure, with 15 subsidiaries recorded beneath it across 10 jurisdictions. Those 15 subsidiaries span Germany, Norway, Czechia, Finland, Italy, Denmark, and 4 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 15 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Medac Gesellschaft für klinische Spezialpräparate m.b.H.'s ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to Medac Gesellschaft für klinische Spezialpräparate m.b.H.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Medac Gesellschaft für klinische Spezialpräparate m.b.H.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like Medac Gesellschaft für klinische Spezialpräparate m.b.H.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 5 October 2026.